Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women.

Sapino A, Righi L, Cassoni P, Papotti M, Gugliotta P, Bussolati G.

Mod Pathol. 2001 Aug;14(8):768-76.

2.

Histiocytoid breast carcinoma: histological, immunohistochemical, ultrastructural, cytological and clinicopathological studies.

Shimizu S, Kitamura H, Ito T, Nakamura T, Fujisawa J, Matsukawa H.

Pathol Int. 1998 Jul;48(7):549-56. Review.

PMID:
9701019
3.
4.

Expression of the neuroendocrine phenotype in carcinomas of the breast.

Sapino A, Righi L, Cassoni P, Papotti M, Pietribiasi F, Bussolati G.

Semin Diagn Pathol. 2000 May;17(2):127-37. Review.

PMID:
10839613
5.

The neuroendocrine phenotype in prostate cancer: basic and clinical aspects.

Mosca A, Berruti A, Russo L, Torta M, Dogliotti L.

J Endocrinol Invest. 2005;28(11 Suppl International):141-5. Review.

PMID:
16625864
6.

Diagnostic cytological features of neuroendocrine differentiated carcinoma of the breast.

Sapino A, Papotti M, Pietribiasi F, Bussolati G.

Virchows Arch. 1998 Sep;433(3):217-22. Review.

PMID:
9769124
7.

[Breast carcinoma metastatic to meningioma: review of the literature and description of 2 new cases].

Fornelli A, Bacci A, Collina G, Eusebi V.

Pathologica. 1995 Oct;87(5):506-12. Review. Italian.

PMID:
8868176
8.

Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen- and androgen-like steroids.

Hackenberg R, Schulz KD.

J Steroid Biochem Mol Biol. 1996 Jan;56(1-6 Spec No):113-7. Review.

PMID:
8603031
9.

Molecular pathology of breast apocrine carcinomas: a protein expression signature specific for benign apocrine metaplasia.

Celis JE, Gromova I, Gromov P, Moreira JM, Cabezón T, Friis E, Rank F.

FEBS Lett. 2006 May 22;580(12):2935-44. Epub 2006 Apr 12. Review.

10.

[Breast carcinoma with predominant neuroendocrine differentiation].

Frachon S, Pasquier D, Treilleux I, Seigneurin D, Ringeisen F, Rosier P, Bolla M, Boutonnat J.

Ann Pathol. 2004 Jun;24(3):278-83. Review. French.

PMID:
15480266
11.

Gross cystic disease fluid protein (GCDFP-15) in the breast: past and present.

Sapino A, Cassoni P, Bussolati G.

J Biol Regul Homeost Agents. 2000 Oct-Dec;14(4):259-62. Review. No abstract available.

PMID:
11215813
12.

Encapsulated papillary carcinoma, apocrine type, of the breast.

Kuroda N, Fujishima N, Hayes MM, Moritani S, Ichihara S.

Malays J Pathol. 2014 Aug;36(2):139-43. Review.

13.

Steroid biochemistry and categorization of breast cyst fluid: relation to breast cancer risk.

Angeli A, Dogliotti L, Naldoni C, Orlandi F, Puligheddu B, Caraci P, Bucchi L, Torta M, Bruzzi P.

J Steroid Biochem Mol Biol. 1994 Jun;49(4-6):333-9. Review.

PMID:
8043497
14.

Divergent differentiation in neuroendocrine lung tumors.

Brambilla E, Lantuejoul S, Sturm N.

Semin Diagn Pathol. 2000 May;17(2):138-48. Review.

PMID:
10839614
15.

Morphologic and functional aspects of apocrine metaplasia in dysplastic and neoplastic breast tissue.

Bussolati G, Cattani MG, Gugliotta P, Patriarca E, Eusebi V.

Ann N Y Acad Sci. 1986;464:262-74. Review. No abstract available.

PMID:
3524352
16.

Review of GCDFP-15. An apocrine marker protein.

Haagensen DE Jr, Dilley WG, Mazoujian G, Wells SA Jr.

Ann N Y Acad Sci. 1990;586:161-73. Review. No abstract available.

PMID:
2192632
17.

Divergent neuroendocrine differentiation in prostatic carcinoma.

di Sant' Agnese PA.

Semin Diagn Pathol. 2000 May;17(2):149-61. Review.

PMID:
10839615
18.

Metaplastic breast carcinoma: a cytohistologic and clinical study of 10 cases.

Johnson TL, Kini SR.

Diagn Cytopathol. 1996 May;14(3):226-32. Review.

PMID:
8732652
19.
20.

Solid papillary carcinoma of the breast: a pathologically and clinically distinct breast tumor.

Saremian J, Rosa M.

Arch Pathol Lab Med. 2012 Oct;136(10):1308-11. Review.

PMID:
23020734

Supplemental Content

Support Center